The global sexual enhancement supplements market is expected to be valued at US$ 257.7 million in 2023 and reach a valuation of US$ 741.6 million by 2033. The demand for sexual enhancement supplements is estimated to record a 7.4% CAGR.
The growth of the global sexual enhancement supplements market is being driven by multiple key factors. One of the most important drivers is the growing awareness and willingness of people to address sexual health issues. With increased openness and awareness about sexual health, there has been a rise in demand for products that can enhance sexual performance and well-being. People are becoming conscious of the impact of stress, lifestyle, and aging on their sexual health, and are seeking products that can help improve their sexual function.
The overall health and wellness industry is also growing globally, with people becoming increasingly conscious of the importance of preventive healthcare and taking proactive steps to maintain their health and wellness. This includes products related to sexual health, leading to a growing demand for sexual enhancement supplements.
Other drivers of the growth of the global sexual enhancement supplements market include the aging population, changing attitudes towards sexual health, advances in technology and product innovation, rise in prevalence of stress and lifestyle-related health problems, marketing and promotion, growing acceptance of alternative medicine, increasing prevalence of erectile dysfunction, growing popularity of performance-enhancing supplements, growing interest in sexual wellness, and increasing awareness about sexual health. The availability of a diverse range of sexual enhancement supplements, including natural and herbal-based products, is also contributing to the growth of the market.
Another factor is the growth of the global middle class and the increase in disposable income. This has led people to invest more in their health and well-being, including sexual health. In developing countries, rising income levels are particularly driving demand for high-quality and premium sexual enhancement supplements.
The growing health and wellness industry is also playing a role, as people become conscious of the importance of preventive healthcare and take proactive steps to maintain their health and well-being, including their sexual health. The influence of popular culture and media, which are increasingly promoting and normalizing the use of supplements and products to enhance sexual performance and well-being, has also helped remove the stigma around sexual health and made people more open to seeking solutions to their sexual health problems.
| Attributes | Details |
|---|---|
| Sexual Enhancement Supplements Market CAGR (2023 to 2033) | 7.4% |
| Sexual Enhancement Supplements Market Size (2023) | US$ 257.7 million |
| Sexual Enhancement Supplements Market Size (2033) | US$ 741.6 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global need for sexual enhancement supplements is anticipated to expand at a CAGR of 7.4% between 2023 and 2033. The growth potential of the demand for sexual enhancement supplements could be looked at from short-term, mid-term, and long-term perspectives.
| Short-term Outlook | The rise in stress and lifestyle-related health problems, such as obesity, diabetes, and heart disease, which can impact sexual health, is driving demand for sexual enhancement supplements in the short term. |
|---|---|
| Mid-term Outlook | An aging population means an increasing number of people experiencing age-related sexual health problems, which is expected to lead to higher demand for sexual enhancement supplements in the midterm. |
| Long-term Outlook | Advances in technology and product innovation have led to the development of new and improved sexual enhancement supplements, which are more effective and have fewer side effects. |
The global market for sexual enhancement supplements is being fueled by multiple key factors. One is the increasing openness and awareness about sexual health issues, which has led to a rise in demand for products that can improve sexual performance and well-being. People are becoming more aware of the impact of factors such as stress, lifestyle, and aging on their sexual health, and are seeking solutions to improve their sexual function. Therefore, the treatment for sexual illnesses or dysfunctions may seem to be a topic that is difficult to address, but it’s a needful step towards health wellness.
The rise of e-commerce has made it easier for people to purchase sexual enhancement supplements discreetly and conveniently, as e-commerce platforms offer a wider range of products and make it easier for consumers to find products that suit their needs and preferences. Finally, a growing global population is leading to a larger potential consumer base for sexual enhancement supplements, and as populations continue to grow, so does the demand for these products.
As people become open and aware of sexual health issues, there has been a rise in demand for supplements and products that can enhance sexual performance and well-being. With a growing middle class and higher disposable income, people are willing to invest in their health and well-being, including sexual health.
The overall health and wellness industry in the United States is growing, and this includes products related to sexual health. Popular culture and media are increasingly promoting and normalizing the use of supplements and products to enhance sexual performance and well-being. The rise of e-commerce has made it easier for people to purchase sexual enhancement supplements discreetly and conveniently.
The United Kingdom has a well-established healthcare system and a history of high standards for quality and safety in the supplements market. Additionally, the country has a high level of consumer awareness and willingness to spend on personal health, which could continue to drive demand for sexual enhancement supplements.
The competition from other countries, particularly in Asia, is increasing as the market for these products grows globally. For the United Kingdom to maintain its dominance in this market, it is expected to be important for companies to keep up with consumer trends and demand, and to continue to meet high standards for quality and safety.
China has a population of over 1.4 billion, therefore with the rise of the middle class and higher disposable income, people are willing to invest in their health and well-being, including sexual health. Additionally, traditional Chinese culture places a strong emphasis on maintaining balance and harmony in the body, and this extends to sexual health as well. This cultural belief has driven demand for natural remedies and supplements that can enhance sexual performance and overall well-being.
Furthermore, the increasing awareness and openness regarding sexual health issues in China have led to a growing market for sexual enhancement supplements. This has been further facilitated by the rise of e-commerce platforms, making it easier for consumers to purchase such products discreetly and conveniently.
The Indian market is growing rapidly due to increasing awareness about sexual health and wellness, and the rising demand for natural and herbal sexual enhancement supplements. In addition, the increasing prevalence of sexual dysfunctions due to changing lifestyle patterns and the growing population of aging individuals are driving the demand for sexual enhancement supplements in India. Moreover, the government is promoting the use of natural and herbal products, and this is further fueling the growth of the sexual enhancement supplements market in India.
However, the market faces some challenges, such as a lack of standardization and regulation of these products, and low awareness among consumers about the benefits and side effects of sexual enhancement supplements. Nevertheless, with increasing investment in the market and growing demand for quality products, the sexual enhancement supplements market in India is expected to grow significantly in the coming years.
Principal Consultant
The growth of the male segment in the sexual enhancement supplements market is expected to be substantial in the coming years. This is due to the growing incidences of sexual dysfunction among men worldwide, which is driving the demand for these supplements. The increasing prevalence of lifestyle diseases such as diabetes, heart disease, obesity, and hypertension in men is also contributing to the growth of the male sexual enhancement supplements market, both in terms of volume and value. As these health conditions increase the risk of sexual problems, it is anticipated that the sales of male sexual enhancement supplements continue to rise in the forecast period.
The market is competitive and multiple competitive strategies are being followed by companies to gain an advantage. Some examples of these strategies include
Branding and Marketing: Companies focus on creating a strong brand image and promoting their products through various marketing channels, such as social media, influencer marketing, and paid advertising. For example, ExtenZe, a male sexual enhancement supplement, has a strong brand image and has been heavily marketed through infomercials and celebrity endorsements.
Pricing strategy: Companies adopt different pricing strategies, such as premium pricing, value-based pricing, or discount pricing, to attract customers. For example, ProSolution Plus, a male sexual enhancement supplement, offers a value-based pricing strategy and provides customers with a money-back guarantee.
Focus on Research and Development: Companies invest heavily in research and development to create innovative and high-quality sexual enhancement supplements. For example, HerSolution, a female sexual enhancement supplement, uses a proprietary blend of natural ingredients and is backed by scientific research.
Customer Service and Support: Companies provide excellent customer service and support to build customer loyalty and satisfaction. For example, Volume Pills, a male sexual enhancement supplement, offers a comprehensive customer support program and a 67-day money-back guarantee.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Arkopharma Laboratories
Arkopharma Laboratories is a French company specializing in the production and distribution of natural health products, including dietary supplements, herbal remedies, and cosmetics. Founded in 1979, Arkopharma is one of the leading companies in the natural health market in Europe. The company operates in over 50 countries and is known for its commitment to using high-quality, natural ingredients in its products.
Dabur India Ltd.
Dabur India Ltd. is an Indian multinational consumer goods company based in New Delhi, India. It was founded in 1884 and is one of the leading Ayurvedic medicine manufacturers in India. Dabur offers a wide range of products, including health care, personal care, and food products. The company's healthcare division includes products such as herbal supplements, Ayurvedic medicines, and probiotics.
Lovehoney Group Ltd.
Lovehoney Group Ltd. is a United Kingdom-based company that specializes in the production and distribution of sexual wellness products, including sexual enhancement supplements. Lovehoney was founded in 2002 and has since become one of the leading online retailers of sexual health products in the United Kingdom. These products may contain ingredients such as herbs, vitamins, minerals, and amino acids that are believed to support sexual health.
The market is valued at US$ 257.7 million in 2023.
The Indian market is growing rapidly due to increasing awareness about sexual health and wellness.
By 2033, the market will reach US$ 741.6 million.
The market CAGR through 2033 is 7.4%.
China is considered an attractive market owing to the increasing awareness regarding sexual health issues.
1. Executive Summary | Sexual Enhancement Supplements Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Female Sexual Enhancement Supplements
5.3.2. Male Sexual Enhancement Supplements
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033
6.3.1. Online Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Hospital Pharmacies
6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Dosage Form
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Dosage Form , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Dosage Form , 2023 to 2033
7.3.1. Dietary Products
7.3.2. Gels
7.3.3. Creams
7.3.4. Essential Oils
7.3.5. Sprays
7.3.6. Lotions
7.4. Y-o-Y Growth Trend Analysis By Dosage Form , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Dosage Form , 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Distribution Channel
9.2.4. By Dosage Form
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Distribution Channel
9.3.4. By Dosage Form
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Distribution Channel
10.2.4. By Dosage Form
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Distribution Channel
10.3.4. By Dosage Form
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product Type
11.2.3. By Distribution Channel
11.2.4. By Dosage Form
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Distribution Channel
11.3.4. By Dosage Form
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. Singapore
12.2.1.5. Thailand
12.2.1.6. Indonesia
12.2.1.7. Australia
12.2.1.8. New Zealand
12.2.1.9. Rest of Asia Pacific
12.2.2. By Product Type
12.2.3. By Distribution Channel
12.2.4. By Dosage Form
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Distribution Channel
12.3.4. By Dosage Form
12.4. Key Takeaways
13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Product Type
13.2.3. By Distribution Channel
13.2.4. By Dosage Form
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Distribution Channel
13.3.4. By Dosage Form
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. USA
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2022
14.1.2.1. By Product Type
14.1.2.2. By Distribution Channel
14.1.2.3. By Dosage Form
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2022
14.2.2.1. By Product Type
14.2.2.2. By Distribution Channel
14.2.2.3. By Dosage Form
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2022
14.3.2.1. By Product Type
14.3.2.2. By Distribution Channel
14.3.2.3. By Dosage Form
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2022
14.4.2.1. By Product Type
14.4.2.2. By Distribution Channel
14.4.2.3. By Dosage Form
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2022
14.5.2.1. By Product Type
14.5.2.2. By Distribution Channel
14.5.2.3. By Dosage Form
14.6. United kingdom
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2022
14.6.2.1. By Product Type
14.6.2.2. By Distribution Channel
14.6.2.3. By Dosage Form
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2022
14.7.2.1. By Product Type
14.7.2.2. By Distribution Channel
14.7.2.3. By Dosage Form
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2022
14.8.2.1. By Product Type
14.8.2.2. By Distribution Channel
14.8.2.3. By Dosage Form
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2022
14.9.2.1. By Product Type
14.9.2.2. By Distribution Channel
14.9.2.3. By Dosage Form
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2022
14.10.2.1. By Product Type
14.10.2.2. By Distribution Channel
14.10.2.3. By Dosage Form
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2022
14.11.2.1. By Product Type
14.11.2.2. By Distribution Channel
14.11.2.3. By Dosage Form
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2022
14.12.2.1. By Product Type
14.12.2.2. By Distribution Channel
14.12.2.3. By Dosage Form
14.13. Singapore
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2022
14.13.2.1. By Product Type
14.13.2.2. By Distribution Channel
14.13.2.3. By Dosage Form
14.14. Thailand
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2022
14.14.2.1. By Product Type
14.14.2.2. By Distribution Channel
14.14.2.3. By Dosage Form
14.15. Indonesia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2022
14.15.2.1. By Product Type
14.15.2.2. By Distribution Channel
14.15.2.3. By Dosage Form
14.16. Australia
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2022
14.16.2.1. By Product Type
14.16.2.2. By Distribution Channel
14.16.2.3. By Dosage Form
14.17. New Zealand
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2022
14.17.2.1. By Product Type
14.17.2.2. By Distribution Channel
14.17.2.3. By Dosage Form
14.18. GCC Countries
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2022
14.18.2.1. By Product Type
14.18.2.2. By Distribution Channel
14.18.2.3. By Dosage Form
14.19. South Africa
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2022
14.19.2.1. By Product Type
14.19.2.2. By Distribution Channel
14.19.2.3. By Dosage Form br /> 14.20. Israel
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2022
14.20.2.1. By Product Type
14.20.2.2. By Distribution Channel
14.20.2.3. By Dosage Form
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product Type
15.3.3. By Distribution Channel
15.3.4. By Dosage Form
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Direct Digital
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Leading Edge Health
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Arkopharma Laboratories
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Dabur India Ltd.
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. DCC Plc
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Eli Lilly and Company
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. GNC Holdings Inc.
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. Herbalife Nutrition Ltd.
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. Hi-Tech Pharmaceuticals Inc.
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. NOW Foods
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Consumer Product Insights
View Reports
Sexual Enhancement Supplements Market
